Search results
Results from the WOW.Com Content Network
This is a list of investigational autism and pervasive developmental disorder drugs, or drugs that are currently under development for clinical use in the treatment of autistic spectrum disorders and/or other pervasive developmental disorders but are not yet approved.
In January 2018, Roche announced that the US Food and Drug Administration (FDA) had granted breakthrough therapy designation for balovaptan in people with autism spectrum disorder (ASD). [3] The FDA granted this based on the results of the adult phase II clinical trial called VANILLA (Vasopressin ANtagonist to Improve sociaL communication in ...
This is a list of psychiatric medications used by psychiatrists and other physicians to treat mental illness or distress. The list is ordered alphabetically according to the condition or conditions, then by the generic name of each medication. The list is not exhaustive and not all drugs are used regularly in all countries.
Studies supporting those claims had significant flaws, so those data were inadequate to guide treatment recommendations. [156] [180] Vitamin C decreased stereotyped behavior in a small 1993 study. [181] The study had not been replicated as of 2005, and vitamin C had limited popularity as an autism treatment.
Lithium is approved by the FDA for the treatment of bipolar disorder and is widely prescribed off-label as a treatment for major depressive disorder, [12] often as an augmentation agent. Lithium is recommended for the treatment of schizophrenic disorders only after other antipsychotics have failed; it has limited effectiveness when used alone. [13]
The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug Administration Dec. 20 press release.
Dr. Lembke is referring to a 2022 study in Denmark that examined how people with alcohol use disorder respond to a GLP-1 medication versus a sugar pill while also receiving cognitive behavioral ...
Assembly Bill 56 would require social media platforms to warn users about the platform's potential mental health risks to young people. Proposed California law would require warning labels on ...